Mutant strain of filamentous fungus and use therefor

US10844100B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10844100-B2
Application numberUS-201716321101-A
CountryUS
Kind codeB2
Filing dateAug 2, 2017
Priority dateAug 2, 2016
Publication dateNov 24, 2020
Grant dateNov 24, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A filamentous fungus mutant strain showing improved secretory protein production and a method of producing a protein using the filamentous fungus are provided. The method of producing a protein comprises a step of culturing a filamentous fungus mutant strain in which a function of tubulin is reduced or lost and collecting a protein from a culture product.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of producing a protein, the method comprising culturing a filamentous fungus mutant strain under conditions in which the protein is produced, wherein, in the mutant strain, a function of tubulin is reduced or lost, wherein the function of tubulin that is reduced or lost is (i) expression of α-tubulin or β-tubulin or both, and (ii) the formation of α-tubulin and β-tubulin heterodimers, as compared to that in the mutant's parent strain, and collecting the protein from a culture product of the culturing. 2. The method according to claim 1 , wherein the expression of α-tubulin is reduced or lost. 3. The method according to claim 1 , wherein the expression of β-tubulin is reduced or lost. 4. The method according to claim 1 , wherein the reduced or lost function of tubulin is the result of deleting or inactivating a gene encoding α-tubulin. 5. The method according to claim 1 , wherein the reduced or lost function of tubulin is the result of deleting or inactivating a gene encoding β-tubulin. 6. The method according to claim 4 , wherein the gene encoding α-tubulin comprises any of the following polynucleotides (a) to (f): (a) a polynucleotide having the nucleotide sequence of SEQ ID NO: 1 or 3; (b) a polynucleotide having a nucleotide sequence with an identity of 80% or more with the nucleotide sequence of SEQ ID NO: 1 or 3 and encoding a protein that forms microtubules with β-tubulin in the mutant's parent strain; (c) a polynucleotide that hybridizes to a complementary strand of the polynucleotide having the nucleotide sequence of SEQ ID NO: 1 or 3 under stringent conditions that require the polynucleotide that hybridizes to the complementary strand have 80% or more identity to SEQ ID NO: 1 or 3, and wherein the polynucleotide encodes a protein that forms microtubules with β-tubulin in the mutant's parent strain; (d) a polynucleotide encoding a protein having the amino acid sequence of SEQ ID NO: 2 or 4; (e) a polynucleotide encoding a protein having the amino acid sequence of SEQ ID NO: 2 or 4 in which one or several amino acids are deleted, substituted, added or inserted and that forms microtubules with β-tubulin in the mutant's parent strain; and (f) a polynucleotide encoding a protein having an amino acid sequence with an identity of 80% or more with the amino acid sequence of SEQ ID NO: 2 or 4 and that forms microtubules with β-tubulin in the mutant's parent strain. 7. The method according to claim 5 , wherein the gene encoding β-tubulin is comprises any of the following polynucleotides (g) to (l): (g) a polynucleotide having the nucleotide sequence of SEQ ID NO: 5, 7, 9, 11, or 13; (h) a polynucleotide having a nucleotide sequence with an identity of 80% or more with the nucleotide sequence of SEQ ID NO: 5, 7, 9, 11, or 13 and encoding a protein that forms microtubules with α-tubulin in the mutant's parent strain; (i) a polynucleotide that hybridizes to a complementary strand of the polynucleotide having the nucleotide sequence of SEQ ID NO: 5, 7, 9, 11, or 13 under stringent conditions that require the polynucleotide that hybridizes to the complementary strand have 80% or more identity to SEQ ID NO: 5, 7, 9, 11 or 13, and wherein the polynucleotide encodes a protein that forms microtubules with α-tubulin in the mutant's parent strain; (j) a polynucleotide encoding a protein having the amino acid sequence of SEQ ID NO: 6, 8, 10, 12, or 14; (k) a polynucleotide encoding a protein having the amino acid sequence of SEQ ID NO: 6, 8, 10, 12, or 14 in which one or several amino acids are deleted, substituted, added or inserted and that forms microtubules with α-tubulin in the mutant's parent strain; and (l) a polynucleotide encoding a protein having an amino acid sequence with an identity of 80% or more with the amino acid sequence of SEQ ID NO: 6, 8, 10, 12, or 14 and that forms microtubules with α-tubulin in the mutant's parent strain. 8. The method according to claim 1 , wherein the filamentous fungus is a filamentous fungus belonging to Acremonium, Aspergillus, Chrysosporium, Fusarium, Humicola, Myceliophthora, Neurospora, Penicillium, Talaromyces, Thermoascus, Thielavia , or Trichoderma. 9. The method according to claim 8 , wherein the filamentous fungus is a Trichoderma filamentous fungus. 10. The method according to claim 1 , wherein the protein is one or more selected from the group consisting of cellulase, xylanase, protease, lipase, exoglucanase, endoglucanase, β-glucosidase, mannase, arabinase, arabinofuranosidase, galactase, and amylase. 11. The method according to claim 10 , wherein the protein is cellulase and/or xylanase. 12. The method according to claim 11 , wherein the filamentous fungus mutant strain is cultured in the presence of a cellulase inducer selected from the group consisting of cellulose, sophorose, and a cellooligosaccharide, and cellulase or xylanase is collected from a culture product. 13. The method of claim 4 , wherein the protein encoded by the α-tubulin gene has the amino acid sequence of SEQ ID NO:2. 14. The method of claim 5 , wherein the protein encoded by the β-tubulin gene has the amino acid sequence of SEQ ID NO: 6.

Assignees

Inventors

Classifications

  • C12P21/02Primary

    having a known sequence of two or more amino acids, e.g. glutathione · CPC title

  • Trichoderma · CPC title

  • Fungi {; Processes using fungi} · CPC title

  • Fungi isolates · CPC title

  • General methods for enhancing the expression · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10844100B2 cover?
A filamentous fungus mutant strain showing improved secretory protein production and a method of producing a protein using the filamentous fungus are provided. The method of producing a protein comprises a step of culturing a filamentous fungus mutant strain in which a function of tubulin is reduced or lost and collecting a protein from a culture product.
Who is the assignee on this patent?
Kao Corp
What technology area does this patent fall under?
Primary CPC classification C12P21/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).